New nanoparticle technology to decipher structure and function of membrane...
Researchers at Karolinska Institutet, Sweden, have developed a nanoparticle technology that can be used to stabilise membrane proteins so that their structure can be studied in a lipid environment.
View ArticleSweet 'quantum dots' light the way for new HIV and Ebola treatment
A research team led by the University of Leeds has observed for the first time how HIV and Ebola viruses attach to cells to spread infection.
View ArticleStanford scientists resurrect an abandoned drug, find it effective against...
Viruses have proven to be wily foes. Attempts to fend off viruses causing even the common cold or flu have failed, and new viral outbreaks such as dengue, Ebola or Zika continue to elude drugs.
View ArticleAutomated Ebola blood test performs well in field evaluation
An automated "sample-to-answer" system could provide Ebola virus disease (EVD) diagnosis more quickly and easily than the current standard test, according to research published in PLOS Medicine.
View ArticleEbola in West Africa 'no longer global emergency,' WHO report
Following an expert panel's advice, WHO declare the Ebola situation in West Africa is no longer a global health threat, although small clusters of new cases are still expected.
View ArticleUN's interventions in Sierra Leone significantly slowed Ebola
The United Nations' interventions in the Sierra Leone Ebola outbreak led to a dramatic drop in the transmission of the disease, according to a study led by a University of Florida Health researcher.
View ArticleNIH doctors describe severe case of Ebola virus disease
For more than a month in 2015, a multidisciplinary team including infectious disease and critical care physicians and nurses, respiratory therapists and other specialists at the National Institutes...
View ArticleUninfected or asymptomatic? Diagnostic tests key to forecasting major epidemics
Major epidemics such as the recent Ebola outbreak or the emerging Zika epidemic may be difficult to forecast because of our inability to determine whether individuals are uninfected or infected but...
View ArticleStudy examines safety, immune response of candidate Ebola vaccines
In a study appearing in JAMA, Matthew D. Snape, F.R.C.P.C.H., M.D., of the University of Oxford, United Kingdom, and colleagues conducted a phase 1 trial to evaluate the tolerability and...
View ArticleClinical trial for experimental Ebola drug publishes results
Rapid assessment approach finds TKM-130803 ineffective at the dose given. Results of the Wellcome Trust funded trial of the experimental anti-Ebola drug TKM-130803 have been published April 19 in...
View ArticleInfectious outbreaks must be combatted strategically, Dartmouth-HHS experts...
New funding is not enough to guarantee success against emerging infectious diseases around the world.
View ArticleCellphone-sized device quickly detects the Ebola virus
The worst of the recent Ebola epidemic is over, but the threat of future outbreaks lingers.
View ArticleEbola virus genome provides clues to repeated disease 'flare-ups' in Western...
Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published...
View ArticleCancer drug may treat sepsis, other uncontrollable immune responses to...
NIH-funded study reveals topoisomerase 1 inhibitors suppress inflammation in mice.
View ArticleEbola vaccine: Promising phase I trials
"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo.
View ArticleTowards a pan-ebolavirus treatment
In 2014, the alarm for the Zaire Ebola virus was sounded around the world - but there are other deadly ebolaviruses that cause identical symptoms, and they have even fewer treatment options.
View ArticleReview of Ebola response provides context for future infection control...
National recommendations and strategies are needed to help hospitals prepare for potential Ebola cases and other emerging infectious diseases.
View ArticleNew study sheds light on how some survive Ebola
A first-of-its-kind Ebola study yields clues to how some people are able to survive the deadly virus and suggests possible avenues for treatments that could save more lives.
View ArticleTSRI scientists pinpoint Ebola's weak spots
Scientists at The Scripps Research Institute (TSRI) now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus.
View ArticleHow antiviral antibodies become part of immune memory
Weapons production first, research later. During wartime, governments follow these priorities, and so does the immune system.
View Article
